Figure 2.

Classification of skeletal muscle abnormality phenotypes. Four-muscle abnormality phenotypes included those with no skeletal muscle abnormalities (45%), myosteatosis alone (17%), sarcopenia alone (21%) or concurrent sarcopenia and myosteatosis (17%). * Sarcopenia was defined using established cut-offs in patients with cirrhosis as skeletal muscle index < 50 cm²/m² in males and <39 cm²/m² in females [17]. Myosteatosis was established as muscle radiodensity <33 HU in males and <28 HU in females.